COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …

Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …

COVID-19 had stormed through the world in early March of 2019, and on 5 May 2023, SARS-
CoV-2 was officially declared to no longer be a global health emergency. The rise of new …

First described in December 2019 in Wuhan (China), COVID-19 disease rapidly spread
worldwide, constituting the biggest pandemic in the last 100 years. Even if SARS-CoV-2, the …

The coronavirus 2019 pandemic has affected many healthcare systems worldwide. While
acute respiratory distress syndrome (ARDS) has been well-documented in COVID-19, there …

In this review, we investigated whether severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) can directly cause myocarditis with severe myocardial damage induced by …

Background The coronavirus disease 2019 (COVID-19) pandemic continues to evolve.
Globally, COVID-19 continues to strain even the most resilient healthcare systems, with …

Background: The coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-
CoV-2 virus has resulted in significant mortality and burdening of healthcare resources …

The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity
and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets …

Thromboinflammation, the interplay between thrombosis and inflammation, is a significant
pathway that drives cardiovascular and autoimmune diseases, as well as COVID-19. SARS …